Not yet recruiting
Cardiac failure
Not yet recruitingInvestigational
Study on COR-1167 for Patients with Worsening Heart Failure
Investigational
- Disease:Cardiac failure
- Substances:–
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
Find therapies in clinical trials near you – page 18
- recruiting
- 3 962
- countries
- 28
- conditions
- 2 101
3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today
442 trials match your criteria
Not yet recruiting
Acute leukaemia+2
Not yet recruitingRegistered drugNo placebo
Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant
Registered drugNo placebo
- Disease:Acute leukaemiaAllogenic stem cell transplantation+1
- Substances:CiprofloxacinFOSFOMYCIN CALCIUM+1
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Ciprofloxacin
Not yet recruiting
Soft tissue sarcoma
Not yet recruitingRegistered drugNo placebo
Study of Selinexor and Gemcitabine for Patients with Advanced Soft-Tissue Sarcoma
Registered drugNo placebo
- Disease:Soft tissue sarcoma
- Substances:GemcitabineSelinexor
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Gemcitabine
Not yet recruiting
Soft tissue sarcoma
Not yet recruitingRegistered drugNo placebo
Study of Selinexor and Gemcitabine for Patients with Advanced Soft-Tissue Sarcoma
Registered drugNo placebo
- Disease:Soft tissue sarcoma
- Substances:GemcitabineSelinexor
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Gemcitabine
Not yet recruiting
Breast cancer female
Not yet recruitingRegistered drugNo placebo
Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer
Registered drugNo placebo
- Disease:Breast cancer female
- Substances:AtezolizumabPertuzumab+2
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
Not yet recruiting
Hormone receptor positive HER2 negative breast cancer
Not yet recruitingInvestigationalNo placebo
Study on the Effectiveness of Abemaciclib, Inavolisib, and Giredestrant in Patients with Early HR-positive/HER2-negative Breast Cancer
InvestigationalNo placebo
- Disease:Hormone receptor positive HER2 negative breast cancer
- Substances:AbemaciclibGiredestrant+1
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Abemaciclib
Not yet recruiting
Skin squamous cell carcinoma metastatic+1
Not yet recruitingInvestigationalNo placebo
Study of INCB099280 for Patients With Advanced Cutaneous Squamous Cell Carcinoma Not Suitable for Surgery or Radiotherapy
InvestigationalNo placebo
- Disease:Skin squamous cell carcinoma metastaticSkin squamous cell carcinoma recurrent
- Substances:Incb099280
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Incb099280
Not yet recruiting
Dementia Alzheimer's type
Not yet recruitingInvestigational
Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease
Investigational
- Disease:Dementia Alzheimer's type
- Substances:D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
Not yet recruiting
Pancreatitis acute
Not yet recruitingRegistered drugNo placebo
Study Comparing Sodium Chloride and Lactated Ringer's Solution for Patients with Acute Pancreatitis
Registered drugNo placebo
- Disease:Pancreatitis acute
- Substances:Potassium ChlorideSodium Chloride+2
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Potassium Chloride
Not yet recruiting
Breast cancer
Not yet recruitingRegistered drugNo placebo
Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence
Registered drugNo placebo
- Disease:Breast cancer
- Substances:AnastrozoleExemestane+3
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Anastrozole
Not yet recruiting
Ischaemic stroke
Not yet recruitingInvestigational
Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments
Investigational
- Disease:Ischaemic stroke
- Substances:Redasemtide
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Redasemtide
Not yet recruiting
Transitional cell carcinoma
Not yet recruitingRegistered drugNo placebo
Study Comparing Chemotherapy Before or After Surgery for Patients with Upper Tract Urothelial Carcinoma Using Gemcitabine
Registered drugNo placebo
- Disease:Transitional cell carcinoma
- Substances:Gemcitabine
Countries:Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Gemcitabine